Literature DB >> 11449661

Overview of cefixime use in community-acquired infections.

J M Hamilton-Miller1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11449661     DOI: 10.1111/j.1469-0691.2000.tb02051.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


× No keyword cloud information.
  4 in total

1.  Spray freeze drying to solidify Nanosuspension of Cefixime into inhalable microparticles.

Authors:  Dorrin Mohtadi Haghighi; Homa Faghihi; Majid Darabi; Maryam Saadat Mirmoeini; Alireza Vatanara
Journal:  Daru       Date:  2022-01-08       Impact factor: 4.088

2.  In Vitro Activity of Oral Cephalosporins (Cefprozil and Cefixime) Against Ciprofloxacin-Resistant Enterobacteriaceae from Community-Acquired Urinary-Tract Infections.

Authors:  Aikaterini Pistiki; Thomas Tsaganos; Irene Galani; Evangelos J Giamarellos-Bourboulis
Journal:  Infect Dis Ther       Date:  2015-09-21

3.  COMPARATIVE EFFICACY AND SAFETY OF CEFIXIME AND CIPROFLOXACIN IN THE MANAGEMENT OF ADULTS WITH COMMUNITY-ACQUIRED PNEUMONIA IN IBADAN, NIGERIA.

Authors:  O M Ige; A O Okesola
Journal:  Ann Ib Postgrad Med       Date:  2015-12

4.  Cefixime versus prulifloxacin as a prophylactic treatment for prostate biopsy: a randomized study.

Authors:  Michael Samarinas; Konstantinos Skriapas; Iraklis Mitsogiannis; Stavros Gravas; Anastasios Karatzas; Vasileios Tzortzis
Journal:  Cent European J Urol       Date:  2020-10-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.